554.5

+4.62%↑

SANES

10.724

+1.42%↑

BBVA

19.81

+0.69%↑

BNP

94.58

+0.85%↑

CABK

10.96

+3.01%↑

554.5

+4.62%↑

SANES

10.724

+1.42%↑

BBVA

19.81

+0.69%↑

BNP

94.58

+0.85%↑

CABK

10.96

+3.01%↑

554.5

+4.62%↑

SANES

10.724

+1.42%↑

BBVA

19.81

+0.69%↑

BNP

94.58

+0.85%↑

CABK

10.96

+3.01%↑

554.5

+4.62%↑

SANES

10.724

+1.42%↑

BBVA

19.81

+0.69%↑

BNP

94.58

+0.85%↑

CABK

10.96

+3.01%↑

554.5

+4.62%↑

SANES

10.724

+1.42%↑

BBVA

19.81

+0.69%↑

BNP

94.58

+0.85%↑

CABK

10.96

+3.01%↑

Home・Akcijų sąrašas・AB Science SA

AB Science SA

Uždarymo kaina

1.336 2.61

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.276

Max

1.34

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-5.2M
Pardavimai	515K
Pelno marža	-1,005.243
Darbuotojai	36
EBITDA	-2.5M

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-11

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	84M
Ankstesnė atidarymo kaina	-1.27
Ankstesnė uždarymo kaina	1.336

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

1.426 / 1.448 Palaikymas ir pasipriešinimas

AB Science SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-20 17:37; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

2026-02-20 16:18; UTC

Pagrindinės rinkos jėgos

Footwear Stocks Rise After Supreme Court Strikes Down Tariffs

2026-02-20 23:12; UTC

Įsigijimai, susijungimai, perėmimai

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

2026-02-20 22:12; UTC

Uždarbis

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

2026-02-20 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-20 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-02-20 21:23; UTC

Uždarbis

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

2026-02-20 21:20; UTC

Rinkos pokalbiai

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

2026-02-20 21:01; UTC

Įsigijimai, susijungimai, perėmimai

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

2026-02-20 20:38; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

2026-02-20 20:17; UTC

Rinkos pokalbiai

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

2026-02-20 20:11; UTC

Rinkos pokalbiai

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

2026-02-20 19:59; UTC

Rinkos pokalbiai

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

2026-02-20 19:58; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

2026-02-20 19:49; UTC

Rinkos pokalbiai

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

2026-02-20 19:09; UTC

Rinkos pokalbiai

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

2026-02-20 19:00; UTC

Rinkos pokalbiai

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

2026-02-20 18:28; UTC

Rinkos pokalbiai

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

2026-02-20 18:20; UTC

Rinkos pokalbiai

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

2026-02-20 18:05; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2026-02-20 18:04; UTC

Rinkos pokalbiai

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

2026-02-20 17:38; UTC

Rinkos pokalbiai

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

2026-02-20 17:24; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-20 17:24; UTC

Rinkos pokalbiai

Correction to Treasury Yields Fall Market Talk

2026-02-20 17:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-02-20 16:53; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2026-02-20 16:53; UTC

Rinkos pokalbiai

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

2026-02-20 16:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-20 16:45; UTC

Rinkos pokalbiai

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

2026-02-20 16:40; UTC

Rinkos pokalbiai

Trade Threats Facing Canada Not Removed by Supreme Court's Ruling -- Market Talk

Akcijų palyginimas

Kainos pokytis

AB Science SA Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių AB Science SA akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

1.426 / 1.448Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.